26 May 2026Open access
Design of benzofuro [3,2-d] pyrimidine-based MmpL3 inhibitors as potential anti-tuberculosis agents using integrated in silico approachesIn Silico Pharmacology, Tuberculosis Research and Epidemiology
Active, last published 2026
In computational drug discovery methods
Anne
Jibrin
Scholar“Research focused on Computational Drug Discovery Methods and adjacent fields.”
Ahmadu Bello University
Nigeria
Claim Your ProfileNigeria1
H-index
12
Citations
Anne has not officially claimed their profile. If you are Anne, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
01 · About the work
What I study
nne Jibrin is a researcher working on Computational Drug Discovery Methods. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Anne's work has been cited 12 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Computational Drug Discovery Methods×3Synthesis and biological activity×3
04 · Where I am
Affiliations
CurrentlyAhmadu Bello University, Nigeria
Research themes (UN SDGs)
05 · Selected work
Recent publications
5 works12 May 2026Open access
Computational design and optimization of INHA inhibitors based on 5-amino-1 H-pyrazole-4-carbonitrile for anti-tuberculosis applicationsDiscover Chemistry., Antimicrobial agents and applications
Are you Anne?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
No commitment required